Actinogen Medical Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	2020 - 2016
Net Income	-14.73	-13.04	-10.75	-9.5	-3.92	Upgrade
Depreciation & Amortization	0.42	0.42	0.41	0.4	0.39	Upgrade
Stock-Based Compensation	1.66	1.31	1.52	1.29	0.29	Upgrade
Other Operating Activities	0.01	-0.02	-0	-0.01	-	Upgrade
Change in Accounts Receivable	3.5	-5.2	-0.18	-2.41	1.49	Upgrade
Change in Accounts Payable	1.55	-0.38	0.25	0.69	0.11	Upgrade
Change in Other Net Operating Assets	0.04	-0.04	0.06	0.03	-0.08	Upgrade
Operating Cash Flow	-7.56	-16.95	-8.7	-9.52	-1.72	Upgrade
Capital Expenditures	-0.04	-0.01	-0.04	-0	-0.01	Upgrade
Investing Cash Flow	-0.04	-0.01	-0.04	-0	-0.01	Upgrade
Short-Term Debt Issued	3	-	-	-	-	Upgrade
Total Debt Issued	3	-	-	-	-	Upgrade
Long-Term Debt Repaid	-0.06	-0.09	-0.08	-0.07	-0.08	Upgrade
Net Debt Issued (Repaid)	2.94	-0.09	-0.08	-0.07	-0.08	Upgrade
Issuance of Common Stock	12.24	19.11	0.9	13.32	10.91	Upgrade
Other Financing Activities	-0.53	-1.06	-	-0.83	-0.72	Upgrade
Financing Cash Flow	14.65	17.95	0.82	12.42	10.11	Upgrade
Foreign Exchange Rate Adjustments	-	-	0	0.01	-	Upgrade
Miscellaneous Cash Flow Adjustments	-	-	-	0.04	-	Upgrade
Net Cash Flow	7.05	0.99	-7.91	2.95	8.38	Upgrade
Free Cash Flow	-7.59	-16.96	-8.73	-9.52	-1.73	Upgrade
Free Cash Flow Margin	-138.33%	-170.76%	-178.70%	-261.53%	-87.20%	Upgrade
Free Cash Flow Per Share	-0.00	-0.01	-0.01	-0.01	-0.00	Upgrade
Cash Interest Paid	0.04	0.02	0.02	0.01	0.02	Upgrade
Cash Income Tax Paid	-	-	-	-1.43	-3.03	Upgrade
Levered Free Cash Flow	-2.49	-12.2	-4.86	-5.98	-0.28	Upgrade
Unlevered Free Cash Flow	-2.46	-12.18	-4.85	-5.97	-0.26	Upgrade
Change in Working Capital	5.08	-5.62	0.13	-1.69	1.52	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.